FDA's Pulse Oximeter Guidance Unlikely to End Racial Bias

State attorneys general and US senators have pressed the FDA to take steps to eliminate pulse oximetry's racial bias, which has caused delays in treatment.
KFF Health News

source https://www.medscape.com/s/viewarticle/fdas-pulse-oximeter-guidance-unlikely-end-racial-bias-2024a1000iby?src=rss

Comments

Popular posts from this blog

RA and RA-ILD Linked to Higher Lung Cancer Risk

Heart Failure Care Outside of ICU Can Lower Cost